The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Athenex Inc | COM | 04685N103 | 1,565 | 123,305 | SH | SOLE | 849,979 | 0 | 0 | ||
| Audentes Therapeutics Inc | COM | 05070R104 | 16,293 | 764,193 | SH | SOLE | 43,980 | 0 | 0 | ||
| Bausch Health Cos Inc | COM | 071734107 | 12,280 | 664,837 | SH | SOLE | 500,000 | 0 | 0 | ||
| BioMarin Pharmaceutical Inc | COM | 09061G101 | 29,070 | 341,400 | SH | Call | SOLE | 1,583,954 | 0 | 0 | |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | 2,967 | 376,010 | SH | SOLE | 50,000 | 0 | 0 | ||
| Chiasma Inc | COM | 16706W102 | 3,317 | 1,066,439 | SH | SOLE | 74,132 | 0 | 0 | ||
| Cymabay Therapeutics Inc | COM | 23257D103 | 5,625 | 714,764 | SH | SOLE | 35,000 | 0 | 0 | ||
| Deciphera Pharmaceuticals Inc | COM | 24344T101 | 2,559 | 121,892 | SH | SOLE | 158,712 | 0 | 0 | ||
| Exelixis Inc | COM | 30161Q104 | 6,053 | 307,739 | SH | SOLE | 1,737,397 | 0 | 0 | ||
| Global Blood Therapeutics Inc | COM | 37890U108 | 9,099 | 221,662 | SH | SOLE | 193,279 | 0 | 0 | ||
| Heron Therapeutics Inc | COM | 427746102 | 21,249 | 819,164 | SH | SOLE | 541,172 | 0 | 0 | ||
| Horizon Pharma Plc | SHS | G4617B105 | 7,742 | 396,198 | SH | SOLE | 545,500 | 0 | 0 | ||
| Immunomedics Inc | COM | 452907108 | 12,767 | 894,679 | SH | SOLE | 300,000 | 0 | 0 | ||
| Insmed Inc | COM PAR $.01 | 457669307 | 11,007 | 838,946 | SH | SOLE | 737,303 | 0 | 0 | ||
| MediWound Ltd | ORD SHS | M68830104 | 424 | 104,546 | SH | SOLE | 892,579 | 0 | 0 | ||
| Novartis AG | SPONSORED ADR | 66987V109 | 27,126 | 316,117 | SH | SOLE | 636,646 | 0 | 0 | ||
| Osmotica Pharmaceuticals PLC | SHS | G6S41R101 | 935 | 120,620 | SH | SOLE | 181,011 | 0 | 0 | ||
| SPDR S&P Biotech ETF | S&P BIOTECH | 78464A870 | 35,818 | 499,200 | SH | Put | SOLE | 908,664 | 0 | 0 | |
| Stemline Therapeutics Inc | COM | 85858C107 | 6,760 | 711,558 | SH | SOLE | 30,622 | 0 | 0 | ||
| Sutro Biopharma Inc | COM | 869367102 | 2,250 | 249,496 | SH | SOLE | 1,026,906 | 0 | 0 | ||
| Teva Pharmaceutical Industries | SPONSORED ADR | 881624209 | 25,960 | 1,683,500 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| Vaccinex Inc | COM | 918640103 | 62 | 17,047 | SH | SOLE | 654,532 | 0 | 0 | ||
| Zosano Pharma Corp | COM NEW | 98979H202 | 1,693 | 798,719 | SH | SOLE | 1,735,030 | 0 | 0 | ||